Shaolin Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Shaolin Capital Management’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-105,687	Closed	-$3K	–	799
2022 Q3	$3K	Hold	105,687	–	–	﹤0.01%	910
2022 Q2	$4K	Hold	105,687	–	–	﹤0.01%	948
2022 Q1	$9K	Hold	105,687	–	–	﹤0.01%	916
2021 Q4	$34K	Hold	105,687	–	–	﹤0.01%	720
2021 Q3	$27K	Hold	105,687	–	–	﹤0.01%	558
2021 Q2	$57K	Hold	105,687	–	–	﹤0.01%	507
2021 Q1	$45K	Sell	105,687 -272,019	-72%	-$255K	﹤0.01%	499
2020 Q4	$521K	Buy	+377,706	New	+$348K	0.04%	237

Other funds holding COEPW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Shaolin Capital Management's COEPW Position: Q4 2022 in Review

Shaolin Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2022, closing a stake of 105,687 shares — an estimated $3K sold.

Shaolin Capital Management first reported a position in COEPW in Q4 2020 and held it in 8 quarters. The position peaked at $521K in Q4 2020. 21 funds tracked by Wall St. Rank hold COEPW as of Q4 2022.

Shaolin Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q4 2022 after selling out during the quarter.
Shaolin Capital Management sold 105,687 Coeptis Therapeutics Warrants shares in Q4 2022, an estimated $3K.
Shaolin Capital Management first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 8 quarters.
Shaolin Capital Management's Coeptis Therapeutics Warrants position peaked at $521K in Q4 2020.
21 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2022.

Based on Shaolin Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.